Trial Profile
A Pilot Study of Romidepsin for Therapy of Graft-versus-Host Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Romidepsin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Feb 2017 Status changed from active, no longer recruiting to discontinued.
- 08 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.